Trial Profile
Comparison of Therapeutic Efficacy Between Lobeglitazone and Pioglitazone as Initial Triple Therapy With Metformin and Sitagliptin in Drug-naïve Type 2 Diabetic Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Mar 2023
Price :
$35
*
At a glance
- Drugs Lobeglitazone (Primary) ; Metformin; Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Mar 2021 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 29 Mar 2021 Planned primary completion date changed from 30 Oct 2020 to 31 Dec 2021.
- 04 Oct 2019 Planned End Date changed from 1 Dec 2018 to 31 Dec 2020.